Q&M eyes AI and tech investments for future growth
Firm's new AI platform meant to reduce the chance of misdiagnoses, recommend treatment plans in a more objective, transparent way.
Singapore
A FLAW in the dental industry lies in how some dentists prescribe treatment plans simply because they prefer certain procedures. This comes at the expense of patients, said Ng Chin Siau, chief executive of Q&M Dental Group.
In 2018, Q&M established a company, EM2AI, to work on artificial intelligence (AI) projects that target pain points such as this. EM2AI is now preparing for clinical trials to get approval from the Health Sciences Authority for its AI platform, under the Class B medical device category.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
S&P slashes Boeing credit outlook as rating hovers above junk status
Honda to spend US$11 billion on EV strategy in Canada
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Mapletree Industrial Trust Q4 DPU rises 0.9% to S$0.0336
Nasdaq’s profit falls as shaky economy keeps IPO revival elusive
iFast Q1 net profit surges on ePension unit performance